Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
04/2008
04/23/2008CN101166706A Hydroquinone long-chain derivative and/or phenoxy long-chain derivative, and pharmaceutical preparation comprising the same
04/22/2008US7361787 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent
04/22/2008US7361198 oxidative hair colorants; which particularly in combination with the often used p-phenylenediamines would give blue shades and afford oxidation colorants with high resistance to external influences, particularly to frequent washing and sunlight
04/22/2008CA2180816C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
04/17/2008WO2008045319A1 Sulfonate-or sulfate-capped anti-misting agents
04/17/2008US20080090913 Sphingolipid-Derived Phamaceutical Compositions
04/16/2008EP1910387A1 Compounds for preparing immunological adjuvant
04/16/2008CN101163796A Cationic lipids and methods of use
04/16/2008CN101163669A Acetylene derivatives
04/16/2008CN101161641A Tricyclic steroid hormone nuclear receptor modulators
04/16/2008CN101161634A Method for preparing optical active 1-(3-methoxy phenyl) ethylamine
04/16/2008CN101161633A Distillation method for obtaining high-purity double N,N-dimethyl amido ether
04/15/2008US7358398 of aromatic groups using transition metal catalysis in compressed carbon dioxide; intermediates
04/15/2008US7358397 By cleavage and reduction of a halogenated p-hydroxyazobenzene formed by diazotizing an aniline and reacting with a halogenated phenol; intermediates for fluoro-containing agrochemicals or chronic bronchitis agents
04/15/2008US7358396 can be resolved using optically active carboxylic acids or enzymes; compounds such as 1-benzyloxy-3-aminobutane
04/15/2008CA2328920C Novel derivatives of 3,3-diphenylpropylamines
04/15/2008CA2154424C 1-phenyl-3-dimethylaminopropane compounds having a pharmaceutical effect
04/10/2008WO2008042362A1 Arylamino-arylpropanolamine derivatives and methods of their use
04/09/2008CN101157623A Method for preparing 1,4-di(4-amino-benzene oxygen) benzene
04/09/2008CN100379719C Substituted aminomethyl-phenyl-cyclohexane derivatives
04/09/2008CN100379717C Corrosion inhibitors comprising nitrogen functionality
04/08/2008US7355079 Thyronamine derivatives and analogs and methods of use thereof
04/08/2008CA2203183C Process for producing derivatives of 4a,5,9,10,11,12,-hexahydro-6h-benzofuro[3a,3,2-ef][2]benzazepine
04/03/2008WO2008037659A1 Method for producing electronic grade 2,2'-aminoethoxyethanol
04/03/2008WO2008037590A1 Method for the continuous separation by distillation of mixtures that contain morpholine (mo), monoaminodiglycol (adg), ammonia and water
04/03/2008DE102007035766A1 Resiststruktur-Verdickungsmarerial, Verfahren zum Ausbilden einer Resiststruktur, Halbleitervorrichtung und Verfahren zum Herstellen derselben Verdickungsmarerial resist pattern, A method of forming a resist pattern, the semiconductor device and method of manufacturing the same
04/03/2008CA2657912A1 Improved processes for preparing venlafaxine base and salts thereof
04/02/2008EP1905758A1 Tamsulosin free base and recovery process thereof
04/02/2008EP1905757A1 Derivatives of Venlafaxine and methods of preparing and using the same
04/02/2008EP1201648B1 Carbamate derivatives and agricultural/horticultural bactericides
04/02/2008CN101155775A Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability
04/02/2008CN101153012A Novel method of producing dronedarone key intermediate
04/02/2008CN100378075C Aniline derivative using as phosphodiesterase 4 inhibitor
04/01/2008US7351865 Synthesis of sterically hindered secondary aminoether alcohols from acid anhydride and/or acid halide and sulfur trioxide
03/2008
03/27/2008WO2008035796A1 Method for producing high-purity quaternary ammonium salt
03/27/2008WO2008035358A2 Process for preparing dapoxetine
03/27/2008US20080076050 P-Terphenyl Compound And Photosensitve Body For Electrophotography Using Such Compound
03/27/2008US20080074045 Organic electroluminescence device
03/26/2008EP1903023A1 Method for manufacturing arylamines
03/26/2008EP1592698B1 Phosphine compound, intermediate, palladium-complex, and use thereof
03/26/2008EP1366015A4 Benzene-1 2-diol mannich bases ligands polymers and method of selective metal ions removal
03/26/2008EP0971878B1 Amine compounds, their production and use as amyloid-beta production inhibitors
03/26/2008CN101148415A Method for preparing 4,6-dialkoxy-1,3-phenylene diamine hydrochlorate
03/26/2008CN100376544C Insulated material monomer in aluminium and copper technology
03/26/2008CN100376324C Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their production and use in catalytic reactions
03/25/2008US7347954 containing a quaternary ammonium salt and an ionic liquid can be converted into a polymer without compromising the excellent properties of the ionic liquid; excellent safety and electrical conductivity
03/20/2008WO2008032616A1 Oligoaniline compounds
03/20/2008US20080070911 Ion channel modulating compounds and uses thereof
03/19/2008CN101146765A Tetrahydronaphthalene derivatives, method for the production and the use thereof in the form of antiphlogistics
03/18/2008CA2298493C Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis
03/13/2008WO2008030771A1 Cyclic alkylidene compounds as selective estrogen receptor modulators
03/13/2008WO2008010764A3 A process for the preparation of substituted 2-acetylamino-alkoxyphenyl
03/13/2008US20080064708 Substituted Pyrazinecarboxylic Acid Anilde Dervatives Or Salts Thereof, Intermediates Of The Same, Pesticides for Agricultural And Horticultural Use, and Usage Thereof
03/12/2008EP1897867A1 Compounds, preparation process, and uses thereof used for interrupting reuptake of 5-hydroxytryptamine and norepinephrine or treating diseases such as depression et al.
03/12/2008EP1896438A1 Phenyl-pyrazole derivatives as non-steroidal glucocorticoid receptor ligands
03/11/2008US7341617 Corrosion and gas hydrate inhibitors having improved water solubility and increased biodegradability
03/06/2008US20080058553 Improved Synthesis of Severely Sterically Hindered Amino-Ether Alcohols and Diaminopolyalkenyl Ethers Using a High Activity Powder Catalyst
03/06/2008US20080058361 Tetrahydrobenzfluorene derivatives
03/06/2008US20080058314 Novel dicarboxylic acid derivatives with pharmaceutical properties
03/05/2008EP1894912A1 Process for producing racemic 3-hydroxy-3-(2-phenylethyl) hexanoic acid ester
03/05/2008EP1893568A2 Monoamine re-uptake inhibitors and methods relating thereto
03/05/2008CN101137615A Phosphate salts of 6-dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexane compounds
03/05/2008CN101137437A Basic ionic liquids
03/05/2008CN101137436A Base stable ionic liquids
02/2008
02/28/2008WO2007141593A3 Process for the preparation of metoprolol and its salts
02/28/2008WO2007086881A3 Cationic lipids and formulated molecular compositions containing them
02/28/2008US20080051605 Amine salts of unsaturated sulfonic acids, e.g. vinylsulfonic acid, tris[2-(2-methoxyethoxy)-ethyl]amine salt; polymerization using 2,2'-azobisisobutyronitrile; capable of a large and polarity dependent response to an electric field; use as actuator, a dielectric material in a capacitor, wetting primer
02/27/2008EP1892235A1 Method for preparing arylpoly(oxyalkyl) amines
02/27/2008EP1890690A2 Mao-b inhibitors useful for treating abesity
02/27/2008EP1718597A4 Improved synthesis of severely sterically hindered amino-ether alcohols and diaminopolyalkenyl ethers using a high activity powder catalyst
02/27/2008EP1718596A4 Catalytic preparation of severely sterically hindered amino-ether alcohols using a metal loaded catalyst
02/27/2008CN101130502A Method for preparing 2,2-dual [3-amido-4-(4-nitrophenoxy)phenyl group]-1,1,1,3,3,3-hexa-fluoropropane
02/27/2008CN100371318C Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
02/27/2008CN100371314C 2-butyl -3-(4 -[3(dibutylamino) propoxy]benzoyl) -5-nitro -benzofuran hydrochloride and preparation thereof
02/26/2008US7335659 Substituted 10-aryl-11H-benzo[b]fluorenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors
02/21/2008WO2008022038A1 Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure
02/21/2008WO2008021533A2 Polymerizable sulfonate ionic liquids and liquid polymers therefrom and methods of making same
02/21/2008US20080045741 Intermediates in producing phenoxyacetic acid derivatives and method of using the same
02/21/2008US20080045740 Alkyl 2-[4-(1-hydroxy-2,2-dialkoxyethyl)-2,5-dimethylphenoxy]acetate, which is an intermediate for preparing alkyl 2-[4-[2-[2-hydroxy-2-(4-hydroxyphenyl)-1-methyethyl]amino]ethyl]-2,5-dimethylphenoxy]acetate
02/21/2008US20080045739 reacting ethyl 2-[4-(2-ethoxy-2-hydroxyethyl)-2,5-dimethylphenoxy]acetat with 2-amino-1-(4-hydroxyphenyl)propan-1-ol and tetrahydrofuran in presence of a reducing agent ( NaBH4) to produce Ethyl (-)-2-[4-[2-[[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyethyl]amino]ethyl]-2,5-dimethylphenoxy]acetate
02/21/2008CA2660707A1 Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure
02/20/2008EP1889828A1 Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability
02/20/2008EP1888506A1 Separation of stereoisomeric n,n-dialkylamino-2-alkyl-3-phenyl alkanes
02/20/2008EP1177166B1 Process for preparing (1r,2s,4r) -(-)-2- (2'- n,n-dimethylamino -ethoxy) -2- phenyl -1,7,7-tri- methyl -bicyclo 2.2.1 heptane and pharmaceutically acceptable acid addition salts thereof
02/20/2008CN101128417A Crystalline forms of (1rs,3rs,6rs)-6-dimethvlaminomethvl-1-(3-methoxv- phenyl)cyclohexane-1 ,3-diol hydrochloride
02/20/2008CN101125819A Method for synthesizing primary octadecylamine polyoxyethylene ether
02/20/2008CN101125137A Pharmaceutical salts
02/19/2008CA2307824C Processes for producing 7-isoindolinequinolonecarboxylic acid derivatives and intermediates therefor,salts of 7-isoindolinequinolonecarboxylic acids, hydrates thereof, and compositions containing the same as active ingredient.
02/14/2008WO2008018447A1 Aminoalcohol derivative and immunosuppressant containing the same as active ingredient
02/14/2008US20080039527 Calixarenes as Inhibitors of Protein Kinase B
02/14/2008CA2659599A1 Amino alcohol derivative and immunosuppressive agent having same as an active ingredient
02/13/2008EP1885684A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta-2 adrenergic receptor
02/13/2008CN101121702A Phenoxy indanone derivatives containing alkylamino side-chain, preparation method and use thereof
02/13/2008CN101121670A Method for preparing 3,4-dimethoxy-N-[3-(4-methoxyphenyl)-1-methyl-n-propyl]-beta-phenylethylamine hydrochloride
02/13/2008CN100368383C Fluorine containing asymmetric aromatic ether diamine and preparation and use thereof
02/13/2008CN100368382C Process of crystallizing separating amino methyl phenoxide mixture
02/12/2008US7329782 Compounds for the treatment of metabolic disorders
02/12/2008US7329771 2,5-xylenol react with an glyoxyl hemiacetyl then etherifying with haloacetic acid ester; Ethyl 2-[4-(2-ethoxy-2-hydroxyethyl)-2,5-dimethylphenoxy] acetate give Ethyl-2-[4-[2-[[-2-hydroxy-2-(4-hydroxyphenyl)-1-methyethyl]amino]ethyl]-2,5-dimethylphenoxy]acetate; high yield; Beta 3-adrenoceptor agonists
02/12/2008CA2285964C Living olefin polymerization processes
02/07/2008WO2008015689A1 A process for the preparation of optically pure r (-) salbutamol and its pharmaceutically acceptable salts
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 140